Related references
Note: Only part of the references are listed.Integrated Whole-Body PET/MRI With 18F-FDG, 18F-FDOPA, and 18F-FDA in Paragangliomas in Comparison With PET/CT NIH First Clinical Experience With a Single-Injection, Dual-Modality Imaging Protocol
Elise M. Blanchet et al.
CLINICAL NUCLEAR MEDICINE (2014)
Diagnostic accuracy of 68Ga-DOTANOC PET/CT imaging in pheochromocytoma
Punit Sharma et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Multimodality Imaging Findings of Pheochromocytoma With Associated Clinical and Biochemical Features in 53 Patients With Histologically Confirmed Tumors
Asim Raja et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2013)
Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening
Lilah F. Morris et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission Tomography: A Meta-analysis
Giorgio Treglia et al.
ACADEMIC RADIOLOGY (2012)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Pacini et al.
ANNALS OF ONCOLOGY (2012)
Genotype-phenotype correlation in multiple endocrine neoplasia type 2
Friedhelm Raue et al.
CLINICS (2012)
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma
David Taieb et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
Giorgio Treglia et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma
Hans H. G. Verbeek et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography
Henri J. L. M. Timmers et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas
Pier Francesco Alesina et al.
LANGENBECKS ARCHIVES OF SURGERY (2012)
Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer
Michael Soussan et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
Guus A. M. S. van Dongen et al.
TUMOR BIOLOGY (2012)
Parathyroid Imaging: The Importance of Dual-Radiopharmaceutical Simultaneous Acquisition with 99mTc-Sestamibi and 123I
Scott A. Caveny et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2012)
Unilateral Subtotal Adrenalectomy for Pheochromocytoma in Multiple Endocrine Neoplasia Type 2 Patients A Feasible Surgical Strategy
Anouk Scholten et al.
ANNALS OF SURGERY (2011)
Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma
Graeme Eisenhofer et al.
CLINICAL CHEMISTRY (2011)
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood
Steven G. Waguespack et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Dual PET/CT with 18F-DOPA and 18F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging
M. C. Marzola et al.
EJSO (2010)
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma
Markus Luster et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
Mohsen Beheshti et al.
EUROPEAN RADIOLOGY (2009)
Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome
Karel Pacak et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2009)
6-[F-18]Fluoro-L-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess
Helle-Brit Fiebrich et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Richard T. Kloos et al.
THYROID (2009)
18F-Dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer:: Relation to tumor differentiation
Klaas P. Koopmans et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A
Maria Philip et al.
JOURNAL OF SURGICAL EDUCATION (2008)
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma
B. Beuthien-Baumann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A
Reza Asari et al.
ARCHIVES OF SURGERY (2006)
Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines
G Eisenhofer et al.
CLINICAL CHEMISTRY (2005)
Surgical management of hereditary pheochromocytoma
L Yip et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Pheochromocytoma: An imaging chameleon
MA Blake et al.
RADIOGRAPHICS (2004)
Parathyroid 99mTc-sestamibi scintigraphy:: dual-tracer subtraction is superior to double-phase washout
WD Leslie et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Biochemical diagnosis of pheochromocytoma - Which test is best?
JWM Lenders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid
M Papotti et al.
CLINICAL ENDOCRINOLOGY (2001)
F-18-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
S Hoegerle et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer
E Kebebew et al.
ARCHIVES OF SURGERY (2000)
Share Paper
